Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$947M |
| 2 |
Tesla
TSLA
|
+$608M |
| 3 |
Microsoft
MSFT
|
+$444M |
| 4 |
Accenture
ACN
|
+$409M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.06B |
| 2 |
Texas Instruments
TXN
|
+$1.92B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.81B |
| 4 |
Starbucks
SBUX
|
+$1.42B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1,000M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.52% |
| 2 | Financials | 7.13% |
| 3 | Consumer Discretionary | 6.46% |
| 4 | Healthcare | 5.43% |
| 5 | Communication Services | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3251
PUT
Arcturus Therapeutics
ARCT
$164M
| $1.04M | ﹤0.01% |
+45,000
| New | +$963K |
|
3252
Smith & Wesson
SWBI
$651M
| $1.04M | ﹤0.01% |
80,449
+56,800
| +240% | +$820K |
|
3253
PUT
Sociedad Química y Minera de Chile
SQM
$19.2B
| $1.04M | ﹤0.01% |
25,000
| – | – |
|
3254
Global Industrial
GIC
$1.37B
| $1.04M | ﹤0.01% |
30,622
+21,097
| +221% | +$693K |
|
|
CRGX
3255
DELISTED
CARGO Therapeutics
CRGX
| $1.04M | ﹤0.01% |
56,354
+39,102
| +227% | +$699K |
|
|
NFBK
3256
DELISTED
Northfield Bancorp
NFBK
| $1.04M | ﹤0.01% |
89,471
+75,182
| +526% | +$862K |
|
3257
Green Dot
GDOT
$743M
| $1.04M | ﹤0.01% |
88,504
+68,481
| +342% | +$716K |
|
3258
Claros Mortgage Trust
CMTG
$250M
| $1.04M | ﹤0.01% |
138,291
+106,289
| +332% | +$884K |
|
|
LPRO
3259
DELISTED
Open Lending Corp
LPRO
| $1.03M | ﹤0.01% |
169,024
+132,561
| +364% | +$763K |
|
3260
Ezcorp Inc
EZPW
$1.83B
| $1.03M | ﹤0.01% |
92,166
+9,328
| +11% | +$102K |
|
3261
IDT Corp
IDT
$1.64B
| $1.03M | ﹤0.01% |
27,066
+19,112
| +240% | +$710K |
|
3262
Metallus
MTUS
$838M
| $1.03M | ﹤0.01% |
69,502
+53,691
| +340% | +$966K |
|
3263
Descartes Systems
DSGX
$6.44B
| $1.03M | ﹤0.01% |
10,008
+270
| +3% | +$26.8K |
|
3264
Heartland Express
HTLD
$948M
| $1.03M | ﹤0.01% |
83,848
+64,185
| +326% | +$788K |
|
|
BRY
3265
DELISTED
Berry Corp
BRY
| $1.03M | ﹤0.01% |
200,120
+121,693
| +155% | +$743K |
|
3266
PUT
Northern Trust
NTRS
$33.3B
| $1.03M | ﹤0.01% |
+11,400
| New | +$997K |
|
3267
indie Semiconductor
INDI
$682M
| $1.02M | ﹤0.01% |
256,799
+197,179
| +331% | +$958K |
|
3268
Myers Industries
MYE
$1.29B
| $1.02M | ﹤0.01% |
74,072
+60,954
| +465% | +$861K |
|
|
HSAI
3269
Hesai Group
HSAI
$2.66B
| $1.02M | ﹤0.01% |
218,240
| – | – |
|
3270
CALL
GSK
GSK
$104B
| $1.02M | ﹤0.01% |
25,000
| – | – |
|
|
ATXS
3271
DELISTED
Astria Therapeutics
ATXS
| $1.02M | ﹤0.01% |
92,651
+38,321
| +71% | +$426K |
|
3272
CALL
RTX Corp
RTX
$290B
| $1.02M | ﹤0.01% |
8,400
-1,111,200
| -99% | -$127M |
|
3273
Haverty Furniture Companies
HVT
$397M
| $1.02M | ﹤0.01% |
37,047
+18,174
| +96% | +$488K |
|
3274
Melco Resorts & Entertainment
MLCO
$2.22B
| $1.02M | ﹤0.01% |
130,545
+103,111
| +376% | +$609K |
|
3275
Alerus Financial
ALRS
$831M
| $1.02M | ﹤0.01% |
44,399
+16,436
| +59% | +$351K |
|
Similar funds
Barclays's Q3 2024 Portfolio in Review
As of Q3 2024, Barclays held 5,593 positions worth $377B, up 15% from $327B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $31.3B of net new capital in Q3 2024, opening 785 new positions and adding to 2,954 existing holdings. Its largest new stake was Smurfit Westrock: 3,460,710 shares worth $171M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $2.06B trimmed.
- Barclays's largest Q3 2024 buy was Smurfit Westrock: 3,460,710 shares worth $171M.
- Barclays added most to iShares US Real Estate ETF in Q3 2024, an estimated $947M increase.
- Barclays's biggest Q3 2024 reduction was CRH, cutting an estimated $2.06B.
- Barclays fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $51.3M.
- Barclays's ten largest holdings make up 41% of its $377B portfolio in Q3 2024.
- Barclays opened 785 new positions and closed 322 in Q3 2024.
- Barclays's portfolio value rose 15% quarter-over-quarter to $377B.
Based on Barclays's 13F filing for Q3 2024, filed 15 Nov 2024.